Annovis Bio Inc (ANVS)
8.29
+0.26
(+3.24%)
USD |
NYSE |
May 17, 16:00
8.30
+0.01
(+0.12%)
Pre-Market: 20:00
Annovis Bio Free Cash Flow: -35.37M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -35.37M |
| December 31, 2023 | -39.97M |
| September 30, 2023 | -34.21M |
| June 30, 2023 | -28.83M |
| March 31, 2023 | -25.92M |
| December 31, 2022 | -17.31M |
| September 30, 2022 | -15.47M |
| June 30, 2022 | -13.23M |
| March 31, 2022 | -9.679M |
| December 31, 2021 | -9.132M |
| September 30, 2021 | -8.129M |
| Date | Value |
|---|---|
| June 30, 2021 | -7.308M |
| March 31, 2021 | -5.475M |
| December 31, 2020 | -3.971M |
| September 30, 2020 | -3.257M |
| June 30, 2020 | -2.379M |
| March 31, 2020 | -1.218M |
| December 31, 2019 | -0.4765M |
| September 30, 2019 | -0.5002M |
| June 30, 2019 | -0.5843M |
| March 31, 2019 | -0.6304M |
| December 31, 2018 | -0.5586M |
Free Cash Flow Range, Past 5 Years
-39.97M
Minimum
Dec 2023
-0.4765M
Maximum
Dec 2019
-13.12M
Average
-8.630M
Median
Free Cash Flow Benchmarks
| ANI Pharmaceuticals Inc | 95.06M |
| Ligand Pharmaceuticals Inc | -19.62M |
| FibroGen Inc | -274.68M |
| SINTX Technologies Inc | -12.44M |
| Stereotaxis Inc | -8.683M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.033M |
| Cash from Financing (Quarterly) | 4.415M |
| Free Cash Flow Per Share (Quarterly) | -0.6497 |
| Free Cash Flow Yield | -43.98% |